Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates

This publication has 16 references indexed in Scilit:

• In vitrocytotoxicity of carcinoma cells with 111In-labeled antibodies to HER-2
  Molecular Cancer Therapeutics, 2005
• Therapy of Small Subcutaneous B-Lymphoma Xenografts with Antibodies Conjugated to Radionuclides Emitting Low-Energy Electrons
  Clinical Cancer Research, 2005
• In vitro Toxicity of A-431 Carcinoma Cells with Antibodies to Epidermal Growth Factor Receptor and Epithelial Glycoprotein-1 Conjugated to Radionuclides Emitting Low-Energy Electrons
  Clinical Cancer Research, 2004
• A Trithiolate Tripodal Bifunctional Ligand for the Radiolabeling of Peptides with Gallium(III)
  Bioconjugate Chemistry, 2002
• Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomas
  Biochemical Journal, 1996
• Synthesis, Purification, and Tumor Cell Uptake of ⁶⁷Ga-Deferoxamine−Folate, a Potential Radiopharmaceutical for Tumor Imaging
  Bioconjugate Chemistry, 1996
• Radiation spectra for Auger‐electron emitting radionuclides: Report No. 2 of AAPM Nuclear Medicine Task Group No. 6
  Medical Physics, 1992
• N,N'-bis(2-hydroxybenzyl)-1-(4-bromoacetamidobenzyl)-1,2-ethylene-diamine-N,N'-diacetic acid: a new bifunctional chelate for radio-labeling antibodies
  Bioconjugate Chemistry, 1990
• A novel derivative of the chelon desferrioxamine for site‐specific conjugation to antibodies
  International Journal of Cancer, 1989
• Gallium radiopharmaceutical chemistry
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1989